Silycus ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 75 | クッシング病 | 1 |
75. クッシング病
臨床試験数 : 205 / 薬物数 : 176 - (DrugBank : 45) / 標的遺伝子数 : 61 - 標的パスウェイ数 : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2020-005605-93-IT (EUCTR) | 21/12/2021 | 22/10/2021 | Efficacy and safety of Silycus® in Cushing’s disease: a multicenter, single arm, openlabel, dose titration, proof of concept study (Silycus®-21) | Efficacy and safety of Silycus® in Cushing’s disease: a multicenter, single arm, openlabel, dose titration, proof of concept study (Silycus®-21) - SILYCUS-21 Trial | Cushing's disease MedDRA version: 20.0;Level: SOC;Classification code 10014698;Term: Endocrine disorders;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Diseases [C] - Hormonal diseases [C19] | Product Name: Silycus Product Code: [na] | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.P.A. | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 15 | Phase 2 | Italy |